In the twenty first century, the changing epidemiology of inflammatory bowel disease (IBD)
globally with increasing disease incidence across many countries relates to the altered gut …

Background Inflammatory bowel disease is a global disease in the 21st century. We aimed
to assess the changing incidence and prevalence of inflammatory bowel disease around the …

Background & Aims Inflammatory bowel diseases (IBDs) exist worldwide, with high
prevalence in North America. IBD is complex and costly, and its increasing prevalence …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

Objective An increasing number of studies have been conducted to look at anxiety and
depression in IBD; however, there is no clear consensus on the prevalence of anxiety and …

Background & Aims The management of inflammatory bowel disease (IBD) poses a
particular challenge during pregnancy because the health of both the mother and the fetus …

Objectives: The incidence of pediatric-onset inflammatory bowel disease (IBD) is increasing
worldwide. We used population-based health administrative data to determine national …

Inflammatory bowel diseases (IBD) are chronic disabling gastrointestinal disorders
impacting every aspect of the affected individual's life and account for substantial costs to the …

In the 21st century, urbanization represents a major demographic shift in developed and
developing countries. Rapid urbanization in the developing world has been associated with …

Background & Aims The medical management of ulcerative colitis (UC) has improved
through the development of new therapies and novel approaches that optimize existing …